Our Centre for Precision Approaches to Combatting Antimicrobial Resistance (AMR) lab, based at Wythenshawe Hospital, has been recognised for their efforts in improving their green credentials
In a major step forward for children with Hunter syndrome, the US Food and Drug Administration (FDA) has approved a new treatment that could significantly change how the condition is managed.
A new study led by researchers at RMCH, has found that some exclusively breastfed babies develop naturally high calcium levels in their blood, but, the condition is harmless and temporary.
The largest ever UK trial of a urine test used across the NHS to spot when patients skip their medication has shown it may improve adherence to treatment.
Advances in AI may enable routine eye tests of the future to detect early signs of heart and brain disease long before symptoms appear, a new study led by Manchester researchers has concluded.